John G Stratton, Director at Abbott Laboratories, bought ABT on May 7, 2026
Data as of Oct 16
- Traded
- May 7, 2026
- Disclosed
- Jun 18, 2026
- Filed
- 42 days after the trade · late
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ABT since disclosure
+18.6%
Similar stocks (XLV) since disclosure
+18.3%
XLV — its sector index fund
Change in closing price from Jun 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.